Norwitz Nicholas G, Mota Adrian Soto, Misra Madhusmita, Ackerman Kathryn E
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Harvard Medical School, Boston, MA, United States.
Front Endocrinol (Lausanne). 2019 Mar 26;10:184. doi: 10.3389/fendo.2019.00184. eCollection 2019.
The Wnt-β-catenin pathway receptor, low-density lipoprotein receptor-related protein 5 (LRP5), is a known regulator of bone mineral density. It has been hypothesized that specific human polymorphisms in impact bone density, in part, by altering the anabolic response of bone to mechanical loading. Although experiments in animal models support this hypothesis, there is limited evidence that polymorphisms can alter the anabolic response of bone to mechanical loading in humans. Herein, we report a young male who harbors a rare missense mutation (A745V) and who provides potential proof of principle for this mechanotransduction hypothesis for low bone density. The subject had no history of fractures until age 18, a year into a career in competitive distance running. As he continued to run over the following 2 years, his mileage threshold to fracture steadily and rapidly decreased until he was diagnosed with severe osteoporosis (lumbar spine BMD Z-score of -3.2). By contextualizing this case within the existing and mechanical stress literature, we speculate that this represents the first documented case of an individual in whom a genetic mutation altered the anabolic response of bone to mechanical stress in a manner sufficient to contribute to osteoporosis.
Wnt-β-连环蛋白通路受体,低密度脂蛋白受体相关蛋白5(LRP5),是一种已知的骨矿物质密度调节因子。据推测,其特定的人类多态性部分通过改变骨骼对机械负荷的合成代谢反应来影响骨密度。尽管动物模型实验支持这一假设,但在人类中,关于多态性可改变骨骼对机械负荷的合成代谢反应的证据有限。在此,我们报告一名年轻男性,他携带一种罕见的错义突变(A745V),为这种低骨密度机械转导假说提供了潜在的原理证明。该受试者在18岁之前没有骨折史,在从事竞技长跑一年后出现骨折。在接下来的两年里,随着他继续跑步,他发生骨折的里程阈值稳步且迅速下降,直到被诊断出患有严重骨质疏松症(腰椎骨密度Z值为-3.2)。通过将该病例置于现有的基因和机械应力文献背景中,我们推测这是首例有记录的因基因突变以足以导致骨质疏松症的方式改变骨骼对机械应力的合成代谢反应的个体病例。